These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28911304)

  • 1. Sialidases: Therapeutic and Antiatherogenic Potential.
    Sukhorukov VN; Karagodin VP; Zakiev ER; Grechko AV; Orekhov AN
    Curr Pharm Des; 2017; 23(31):4696-4701. PubMed ID: 28911304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostics and Therapy of Human Diseases - Focus on Sialidases.
    Karagodin VP; Sukhorukov VN; Myasoedova VA; Grechko AV; Orekhov AN
    Curr Pharm Des; 2018; 24(24):2870-2875. PubMed ID: 30198428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human plasma trans-sialidase donor and acceptor specificity.
    Tertov VV; Nikonova EY; Nifant'ev NE; Bovin NV; Orekhov AN
    Biochemistry (Mosc); 2002 Aug; 67(8):908-13. PubMed ID: 12223090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human plasma trans-sialidase causes atherogenic modification of low density lipoprotein.
    Tertov VV; Kaplun VV; Sobenin IA; Boytsova EY; Bovin NV; Orekhov AN
    Atherosclerosis; 2001 Nov; 159(1):103-15. PubMed ID: 11689212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of developmentally regulated trans-sialidases in the Kinetoplastida and characterization of a shed trans-sialidase activity from procyclic Trypanosoma congolense.
    Engstler M; Schauer R; Brun R
    Acta Trop; 1995 May; 59(2):117-29. PubMed ID: 7676903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospects for the Use of Sialidase Inhibitors in Anti-atherosclerotic Therapy.
    Sobenin IA; Markin AM; Glanz VY; Markina YV; Wu WK; Myasoedova VA; Orekhov AN
    Curr Med Chem; 2021 May; 28(12):2438-2450. PubMed ID: 32867633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sialidase specificity determined by chemoselective modification of complex sialylated glycans.
    Parker RB; McCombs JE; Kohler JJ
    ACS Chem Biol; 2012 Sep; 7(9):1509-14. PubMed ID: 22704707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sialidase substrates for Sialdiase assays - activity, specificity, quantification and inhibition.
    Yuan L; Zhao Y; Sun XL
    Glycoconj J; 2020 Oct; 37(5):513-531. PubMed ID: 32813176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sialidases from gut bacteria: a mini-review.
    Juge N; Tailford L; Owen CD
    Biochem Soc Trans; 2016 Feb; 44(1):166-75. PubMed ID: 26862202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sialic acid metabolism as a potential therapeutic target of atherosclerosis.
    Zhang C; Chen J; Liu Y; Xu D
    Lipids Health Dis; 2019 Sep; 18(1):173. PubMed ID: 31521172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sialidase activity in human pathologies.
    Glanz VY; Myasoedova VA; Grechko AV; Orekhov AN
    Eur J Pharmacol; 2019 Jan; 842():345-350. PubMed ID: 30439363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sialidase Inhibitors with Different Mechanisms.
    Keil JM; Rafn GR; Turan IM; Aljohani MA; Sahebjam-Atabaki R; Sun XL
    J Med Chem; 2022 Oct; 65(20):13574-13593. PubMed ID: 36252951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diversity of sialidases found in the human body - A review.
    Lipničanová S; Chmelová D; Ondrejovič M; Frecer V; Miertuš S
    Int J Biol Macromol; 2020 Apr; 148():857-868. PubMed ID: 31945439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoenzymatic synthesis of sialosides containing C7-modified sialic acids and their application in sialidase substrate specificity studies.
    Khedri Z; Li Y; Muthana S; Muthana MM; Hsiao CW; Yu H; Chen X
    Carbohydr Res; 2014 May; 389():100-11. PubMed ID: 24680514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Atherogenic modification of low-density lipoproteins].
    Sukhorukov VN; Karagodin VP; Orekhov AN
    Biomed Khim; 2016 May; 62(4):391-402. PubMed ID: 27562992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificity of human trans-sialidase as probed with gangliosides.
    Nikonova EY; Tertov VV; Sato C; Kitajima K; Bovin NV
    Bioorg Med Chem Lett; 2004 Oct; 14(20):5161-4. PubMed ID: 15380219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological and Pathological Roles of Ganglioside Sialidases.
    Miyagi T; Takahashi K; Yamamoto K; Shiozaki K; Yamaguchi K
    Prog Mol Biol Transl Sci; 2018; 156():121-150. PubMed ID: 29747812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent development in mammalian sialidase molecular biology.
    Monti E; Preti A; Venerando B; Borsani G
    Neurochem Res; 2002 Aug; 27(7-8):649-63. PubMed ID: 12374200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sialidases in vertebrates: a family of enzymes tailored for several cell functions.
    Monti E; Bonten E; D'Azzo A; Bresciani R; Venerando B; Borsani G; Schauer R; Tettamanti G
    Adv Carbohydr Chem Biochem; 2010; 64():403-79. PubMed ID: 20837202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell surface sialic acid influences tumor cell recognition in the mixed lymphocyte reaction.
    Powell LD; Whiteheart SW; Hart GW
    J Immunol; 1987 Jul; 139(1):262-70. PubMed ID: 2953814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.